The Royal Society of Chemistry (RSC) selected a research study from INL as one of the groundbreaking cancer research papers of 2023. This collection of papers aims to highlight recent developments in efforts to understand cancer and ways to provide effective treatments. In this study published in the journal Nanoscale, the Nanomedicine research group at INL, in collaboration with Stasiuk’s group at King’s College London, developed a new theranostic method for cancer treatment. Theranostics combines therapy and monitoring in a single formulation, offering a more personalised approach to treat cancer. INL researchers developed redox-responsive nanoparticles comprising manganese dioxide and a platinum prodrug, both intended to be activated specifically at the tumour microenvironment. Smart theranostic strategies, also known as responsive theranostics, are approaches in which the drug and/or imaging components are only activated or released in response to a certain stimulus. This stimulus can be a multitude of switches: light, magnetic fields, temperature, ultrasounds, or biological conditions such as the pH or redox state. For example, imagine a scenario where smart theranostic nanoparticles, which are temperature sensitive, are injected into the body, and they travel to a tumour site. When an external trigger, such as an alternating magnetic field or a laser, is […]
Read more